Workflow
债务豁免
icon
Search documents
*ST云网:上海臻禧拟向公司及子公司无偿赠与现金资产1亿元
Ge Long Hui· 2025-12-19 12:58
财经频道更多独家策划、专家专栏,免费查阅>>责任编辑:钟离 格隆汇12月19日丨*ST云网(002306.SZ)公布,接到公司控股股东上海臻禧企业管理咨询合伙企业(有限 合伙)(简称"上海臻禧")通知,为支持公司及子公司业务持续发展及实际经营需求,上海臻禧拟向公 司及子公司无偿赠与现金资产1亿元,同时豁免对公司及子公司所提供借款形成的债务5000万元,上述 现金赠与、债务豁免合计金额为1.5亿元。前述现金赠与、债务豁免不附有任何前提条件,公司及其子 公司单方面获得利益,无需就前述赠与和债务豁免支付任何对价,无需承担任何责任或履行任何义务。 ...
*ST亚太:控股股东无条件豁免公司债务7500万元
本次债务豁免旨在妥善解决公司债务问题,提升公司持续经营能力。豁免生效后,广州万顺将不再要求 公司承担相关责任。公司表示,该事项不存在损害公司和全体股东利益的情形。 截至报告披露日,广州万顺合计持有公司16.40%的表决权股份。 *ST亚太主要从事精细化工产品中的农药中间体、医药中间体的研发、生产和销售。前三季度公司实现 营业总收入3.53亿元,同比增长1.20%。 中证智能财讯*ST亚太(000691)12月10日公告,为支持公司发展、减轻债务压力,公司控股股东广州 万顺技术有限公司决定单方面豁免公司债务本息合计7500万元。本次豁免为无条件、不可撤销,生效后 将相应增加公司资本公积7500万元。 ...
*ST亚太:控股股东豁免公司7500万元债务
Xin Lang Cai Jing· 2025-12-09 12:05
Core Viewpoint - The company *ST亚太 has received a notification from its controlling shareholder, Guangzhou Wanshun, regarding the waiver of debt principal and interest totaling 75 million yuan, which is a unilateral and unconditional action [1] Group 1: Debt Waiver - The waiver includes both principal and interest, amounting to 75 million yuan [1] - This action will reduce the company's other payables by 75 million yuan and correspondingly increase its capital reserve [1] Group 2: Financial Condition - The company is facing a negative net asset situation by the end of 2024 and has been accepted for reorganization [1] - Due to these financial difficulties, the company's stock is under delisting risk warning, and there is a potential risk of bankruptcy and termination of listing if the reorganization fails [1]
中基健康产业股份有限公司第十届董事会第十八次临时会议决议公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:000972 证券简称:*ST中基 公告编号:2025-096号 中基健康产业股份有限公司 第十届董事会第十八次临时会议 决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性陈述或者重大遗 漏。 中基健康产业股份有限公司(以下简称"公司")第十届董事会第十八次临时会议于2025年12月5日(星 期五)以传真通讯方式召开,本次会议于2025年12月1日以电子邮件方式发出会议通知。在确保公司全 体董事充分了解会议内容的基础上,公司9名董事在规定的时间内参加了表决。会议的召开符合《公司 法》和《公司章程》的有关规定。会议审议并一致通过了如下决议: 1、审议通过《关于全资子公司红色番茄拟向股东方六师国资公司借款展期暨关联交易的议案》; 表决结果:同意8票;反对0票;弃权0票。 关联董事袁家东先生回避表决,详见公司于同日披露的《关于全资子公司红色番茄拟向股东方六师国资 公司借款展期暨关联交易的公告》。 2、审议通过《关于子公司获得债务豁免暨关联交易的议案》; 表决结果:同意7票;反对0票;弃权0票。 关联董事袁家东先生、李娟女士 ...
中电鑫龙(002298.SZ):子公司债务豁免
Ge Long Hui A P P· 2025-11-27 13:09
Core Viewpoint - China Electric Xunlong (002298.SZ) has engaged in two smart land projects in Henan Province, which have resulted in significant financial transactions and a debt waiver agreement with a partner company [1][2] Group 1: Project Involvement - The company’s subsidiary, Beijing Zhongdian Xingfa Technology Co., Ltd., participated in the Xiangfu and Xiayi smart land projects in Henan Province [1] - The Xiangfu project has generated cumulative payments of 107 million yuan from the local government, while the Xiayi project has received 48 million yuan from the county's financial and natural resources departments [1] Group 2: Financial Transactions - Beijing Zhongdian Xingfa has paid a total of 116.56 million yuan to Jinshang Company for the Xiangfu project and 62.90 million yuan for the Xiayi project, with a total outstanding payable of 354.72 million yuan to Jinshang [1] - Due to financial pressures, Jinshang Company requested an early payment of 96.22 million yuan from Beijing Zhongdian Xingfa, which agreed to this arrangement while receiving a debt waiver of 258.50 million yuan [2] Group 3: Strategic Implications - The debt waiver is characterized as a market-driven decision that is compliant, reasonable, necessary, and strategically valuable, aimed at improving the operational status and financial structure of Beijing Zhongdian Xingfa [2] - This move aligns with the company's overall development strategy and is not expected to harm the interests of all shareholders [2]
欠债还钱,天经地义?2025年“新规”实施,这5种欠款以后不用还了
Sou Hu Cai Jing· 2025-11-04 10:40
Group 1 - The article discusses five types of debts that may not need to be repaid, highlighting the importance of understanding legal rights regarding debt collection [2][3][4] - The first type of debt is those that exceed the statute of limitations, which is three years for ordinary civil cases, meaning creditors lose the right to pursue repayment if no legal action is taken within this period [2][3] - The second type involves debts without clear evidence, such as verbal agreements without written documentation, making it difficult for creditors to prove the existence of the debt [4][6] Group 2 - The third type pertains to illegal high-interest loans, where any interest exceeding four times the Loan Prime Rate (LPR) is considered invalid, allowing debtors to refuse payment of the excess [7] - The fourth type includes debts that are legally exempted, particularly under the personal bankruptcy system, which allows debtors to discharge remaining debts after certain procedures [8][10] - The fifth type involves unjust enrichment claims that exceed the three-year statute of limitations, meaning that if a debtor is not pursued within this timeframe, they are not obligated to return the funds [11] Group 3 - The article also provides recommendations for lenders to protect their rights, emphasizing the importance of written agreements, maintaining evidence of collection efforts, and using formal channels for transactions [13]
*ST景峰2025年10月24日涨停分析:重整推进+债务豁免+集采中标
Xin Lang Cai Jing· 2025-10-24 01:59
Core Viewpoint - *ST Jingfeng's stock reached the daily limit with a price of 7.05 yuan, reflecting a 5.02% increase, driven by restructuring progress, debt waiver, and successful bids in centralized procurement [1][2]. Company Summary - The company is currently in a transitional phase of restructuring, with Shiyao Group confirmed as the lead investor and a restructuring investment agreement signed, providing hope for the company's future [2]. - Five fund managers waived 110 million yuan in principal and related fees, significantly reducing the company's debt burden, which has boosted market confidence in its future development [2]. - The sale of the "Taihu Star" asset recovered 64.6928 million yuan, helping to optimize the asset structure by divesting loss-making subsidiaries [2]. - The company has successfully won bids for products like sodium hyaluronate injection in several provincial alliances, which is expected to expand market share and improve performance [2]. - In the first half of 2025, the company maintained a certain level of R&D investment and received government subsidies, providing support for its performance [2]. Industry Summary - The pharmaceutical industry has recently attracted market attention, with several stocks in the sector performing actively on October 24, 2025, contributing to *ST Jingfeng's stock limit-up [2]. - Technical indicators suggest that if the MACD forms a golden cross, it could further support the stock price's upward movement [2]. - There may have been capital inflows on the day of the stock limit-up, and it is important to monitor whether this trend continues [2].
江苏蓝丰生物化工股份有限公司 关于签署《和解及债务豁免协议》的公告
Core Viewpoint - Jiangsu Lanfeng Bio-chemical Co., Ltd. has signed a settlement and debt waiver agreement with its controlling shareholder, Jiangsu Suhua Group Co., Ltd., to resolve investor litigation and debt issues, which is expected to alleviate the company's debt pressure and optimize its capital structure [1][7]. Summary by Sections Overview of the Settlement and Debt Waiver - The company faced investor lawsuits due to information disclosure violations, resulting in a compensation requirement of RMB 22,766,475.6, including overdue interest and litigation costs [2]. - As of July 31, 2025, the company owed Jiangsu Suhua Group a total of RMB 83,600,036.66, comprising RMB 59,200,719.70 in principal and RMB 24,399,316.96 in interest [2]. - The company has reached a settlement with Jiangsu Suhua Group regarding the investor lawsuits and debt waiver [2]. Key Terms of the Agreement - Jiangsu Suhua Group will bear a total compensation responsibility of RMB 17,157,200.73 for the investor lawsuits, which will be deducted from the company's outstanding loans to the group [5]. - The agreement includes a waiver of RMB 6,000,000 in interest debt by Jiangsu Suhua Group, which is unconditional and irrevocable [5]. - Following the agreement, the company will not pursue any further claims related to the investor lawsuits against Jiangsu Suhua Group or its management [6]. Impact of the Agreement on the Company - The total amount involved in the settlement and debt waiver is RMB 23,157,200, which will help reduce the company's debt burden and improve its asset-liability structure [7]. - The company will adjust its liabilities according to relevant accounting standards based on the audit results [7].
蓝丰生化:与苏化集团签订《和解及债务豁免协议》
Ge Long Hui· 2025-09-03 09:59
Core Viewpoint - The company has reached a settlement agreement with its controlling shareholder, Jiangsu Suhua Group Co., Ltd., regarding investor litigation claims and debt waiver, which will alleviate the company's debt pressure and optimize its asset-liability structure [1] Summary by Relevant Sections Settlement Agreement - The company convened its 26th meeting of the 7th Board of Directors on September 3, 2025, to approve the signing of a settlement and debt waiver agreement [1] - The total amount involved in the settlement and debt waiver agreement is 23.1572 million yuan [1] Financial Impact - The signing of the agreement is expected to reduce the company's debt burden and improve its financial structure [1] - The company will adjust the liabilities that have been accrued in accordance with relevant provisions of the Enterprise Accounting Standards, with specific amounts to be determined based on audit results [1]
*ST中程财务造假冰山崩塌:公司以退市落幕 股民咋办?
Group 1 - The company *ST Zhongcheng will enter a delisting period starting June 30, 2025, lasting for 15 trading days, with the last trading day expected to be July 18, 2025 [2] - The company reported significant asset impairment in its overseas photovoltaic projects, leading to a negative net asset position and the issuance of a "*ST" warning [3] - A debt waiver of 850 million yuan from three state-owned enterprises was granted to the company, but an audit revealed that a substantial portion of the assets related to the Philippine photovoltaic project was impaired and lacked recoverable evidence [3] Group 2 - The company has been implicated in financial misconduct, with the China Securities Regulatory Commission revealing false financial data related to its Philippine projects from 2017 to 2022, resulting in inflated revenues and profits [4] - The company failed to disclose significant litigation involving its Indonesian subsidiary in 2023, indicating serious information disclosure violations [4]